The National Resident Matching Program, a non-profit organization designed to match prospective residents with residency program directors, has named Kenneth Simons, MD, as a board member, according to a Wauwatosa NOW report.
Ophthalmology
M. Roy Wilson, MD, ophthalmologist and director of strategic scientific planning and program coordination at the National Institute on Minority Health and Health Disparities in Bethesda, Md., has been chosen as the next president of Wayne State University in Detroit,…
Meera Ramanathan, MD, of the Jules Stein Eye Institute at the University of California in Los Angeles, and a team of researchers have identified three predictive factors that determine the risk of progression and visual loss in open-angle glaucoma patients,…
In the UK, Bayer Pharmaceuticals, based in Leverkusen, Germany, has earned approval from the National Institute for Health and Care Excellence for its Eylea as a wet age-related macular degeneration treatment, according to a report by thepharmaletter.
The American Academy of Ophthalmology has released a statement warning Congress of the unintended results of the proposed Pharmaceutical Compounding Quality and Accountability Act, which seeks to crack down on oversights of compounding pharmaceuticals.
Advertisement
BIOLASE, an Irvine, Calif.-based dental laser development and distribution company, has announced that it has earned a U.S. patent covering its laser technologies as a treatment of ophthalmic conditions.
Judy Meyers, DO, has joined the Ophthalmology Associates in Fort Worth, Texas, and will offer optometric services at two of the practice's locations, according to a WatchList News report.
The Association for Research in Vision and Ophthalmology has named Justine Smith, FRANZCO, PhD, FARVO, its new president and William Mieler, MD, its president-elect.
Valeant Pharmaceuticals, based in Quebec, Canada, has acquired ophthalmic products company Bausch + Lomb for $8.7 billion, according to a CNN Money report.
NanoViricides, West Haven, Conn.-based nanobio-pharmaceuticals company, has announced the appointment of Milton Boniuk, MD, as an independent member of its board of directors.